ZA961018B - Oral dosage-forms containing a beta-lactam antibiotic. - Google Patents
Oral dosage-forms containing a beta-lactam antibiotic.Info
- Publication number
- ZA961018B ZA961018B ZA9601018A ZA961018A ZA961018B ZA 961018 B ZA961018 B ZA 961018B ZA 9601018 A ZA9601018 A ZA 9601018A ZA 961018 A ZA961018 A ZA 961018A ZA 961018 B ZA961018 B ZA 961018B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- beta
- lactam antibiotic
- granulate
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200313 | 1995-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA961018B true ZA961018B (en) | 1997-08-08 |
Family
ID=8220003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9601018A ZA961018B (en) | 1995-02-08 | 1996-02-08 | Oral dosage-forms containing a beta-lactam antibiotic. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5948422A (bg) |
EP (1) | EP0801559B1 (bg) |
CN (1) | CN1125636C (bg) |
AT (1) | ATE216576T1 (bg) |
AU (1) | AU4789696A (bg) |
BG (1) | BG63528B1 (bg) |
BR (1) | BR9607189A (bg) |
CZ (1) | CZ293718B6 (bg) |
DE (1) | DE69620866T2 (bg) |
DK (1) | DK0801559T3 (bg) |
EA (2) | EA003736B1 (bg) |
ES (1) | ES2175073T3 (bg) |
HU (1) | HU227938B1 (bg) |
MX (1) | MX9706062A (bg) |
NO (1) | NO319993B1 (bg) |
PL (1) | PL186386B1 (bg) |
PT (1) | PT801559E (bg) |
WO (1) | WO1996024337A1 (bg) |
ZA (1) | ZA961018B (bg) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225402B (en) * | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
CN1225583A (zh) * | 1996-07-16 | 1999-08-11 | 吉斯特-布罗卡迪斯有限公司 | 无有机溶剂的β-内酰胺颗粒 |
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
EP1058538B9 (en) * | 1998-03-06 | 2013-01-02 | Aptalis Pharma S.r.l. | Fast disintegrating tablets |
US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
DE19922537A1 (de) * | 1999-05-10 | 2000-11-16 | Roland Bodmeier | Darreichungsform zur Applikation in Körperöffnungen |
AU2001288102A1 (en) * | 2000-09-22 | 2002-04-02 | Takeda Chemical Industries Ltd. | Solid preparations |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
CA2437375A1 (en) * | 2001-02-05 | 2002-08-15 | R.P. Scherer Technologies, Inc. | Methods and compositions for reducing the taste of pharmaceutically active agents |
AU2003220058B2 (en) * | 2002-03-12 | 2008-05-01 | Toyama Chemical Company Limited | Palatable oral suspension and method |
DE60334391D1 (de) * | 2002-10-02 | 2010-11-11 | Meiji Seika Kaisha | Antibakterielle medizinische zusammensetzung mit erhöhtem oralem absorptionsvermögen |
WO2004056363A2 (en) * | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
JP4926703B2 (ja) * | 2003-07-03 | 2012-05-09 | セルトリ・テクノロジーズ・エルエルシー | セルトリ細胞および筋様細胞を含有する組成物、並びに細胞性移植における該組成物の使用 |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
KR20140053419A (ko) * | 2005-11-17 | 2014-05-07 | 노파르티스 아게 | 약제학적 조성물 |
EP1998748B1 (en) | 2006-03-16 | 2015-01-14 | NicoNovum AB | Improved snuff composition |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
AU2007278850B2 (en) * | 2006-07-28 | 2013-06-06 | Sertocell Biotechnology (Us) Corp. | Adult sertoli cells and uses thereof |
WO2010031552A1 (en) * | 2008-09-17 | 2010-03-25 | Niconovum Ab | Process for preparing snuff composition |
EP2367422A4 (en) * | 2008-12-17 | 2013-01-09 | Altheus Therapeutics Inc | FORMULAS FOR LAVATION |
WO2023204773A1 (en) * | 2022-04-20 | 2023-10-26 | Bilim Ilac Sanayii Ve Ticaret A.S. | Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
DE2251249A1 (de) * | 1972-10-19 | 1974-05-02 | Hoechst Ag | Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten |
DE2251250C3 (de) * | 1972-10-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten |
DE3887179T2 (de) * | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
ES2060737T3 (es) * | 1988-02-25 | 1994-12-01 | Yamanouchi Europ Bv | Procedimiento de preparacion de un granulado farmaceutico. |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
EP0755258B1 (en) * | 1994-04-13 | 2002-01-23 | Research Corporation Technologies, Inc | Methods of treating disease using sertoli cells and allografts or xenografts |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
-
1996
- 1996-02-08 EA EA199900205A patent/EA003736B1/ru not_active IP Right Cessation
- 1996-02-08 EP EP96904039A patent/EP0801559B1/en not_active Expired - Lifetime
- 1996-02-08 WO PCT/EP1996/000547 patent/WO1996024337A1/en active IP Right Grant
- 1996-02-08 AT AT96904039T patent/ATE216576T1/de active
- 1996-02-08 CZ CZ19972302A patent/CZ293718B6/cs not_active IP Right Cessation
- 1996-02-08 MX MX9706062A patent/MX9706062A/es unknown
- 1996-02-08 US US08/894,602 patent/US5948422A/en not_active Expired - Lifetime
- 1996-02-08 AU AU47896/96A patent/AU4789696A/en not_active Abandoned
- 1996-02-08 DK DK96904039T patent/DK0801559T3/da active
- 1996-02-08 PT PT96904039T patent/PT801559E/pt unknown
- 1996-02-08 ZA ZA9601018A patent/ZA961018B/xx unknown
- 1996-02-08 PL PL96321567A patent/PL186386B1/pl unknown
- 1996-02-08 BR BR9607189A patent/BR9607189A/pt active Search and Examination
- 1996-02-08 ES ES96904039T patent/ES2175073T3/es not_active Expired - Lifetime
- 1996-02-08 EA EA199700093A patent/EA000361B1/ru not_active IP Right Cessation
- 1996-02-08 HU HU9801677A patent/HU227938B1/hu not_active IP Right Cessation
- 1996-02-08 CN CN96191852A patent/CN1125636C/zh not_active Expired - Fee Related
- 1996-02-08 DE DE69620866T patent/DE69620866T2/de not_active Expired - Lifetime
-
1997
- 1997-08-07 NO NO19973646A patent/NO319993B1/no not_active IP Right Cessation
- 1997-08-08 BG BG101822A patent/BG63528B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
DE69620866D1 (de) | 2002-05-29 |
PL186386B1 (pl) | 2004-01-30 |
EP0801559B1 (en) | 2002-04-24 |
PT801559E (pt) | 2002-09-30 |
MX9706062A (es) | 1997-10-31 |
CN1173816A (zh) | 1998-02-18 |
PL321567A1 (en) | 1997-12-08 |
WO1996024337A1 (en) | 1996-08-15 |
EA199900205A1 (ru) | 2000-06-26 |
HU227938B1 (en) | 2012-06-28 |
EP0801559A1 (en) | 1997-10-22 |
US5948422A (en) | 1999-09-07 |
EA003736B1 (ru) | 2003-08-28 |
AU4789696A (en) | 1996-08-27 |
NO973646D0 (no) | 1997-08-07 |
EA199700093A1 (ru) | 1998-02-26 |
DK0801559T3 (da) | 2002-06-17 |
CZ293718B6 (cs) | 2004-07-14 |
CN1125636C (zh) | 2003-10-29 |
NO973646L (no) | 1997-09-11 |
DE69620866T2 (de) | 2003-02-27 |
ATE216576T1 (de) | 2002-05-15 |
HUP9801677A3 (en) | 1999-05-28 |
HUP9801677A2 (hu) | 1998-11-30 |
EA000361B1 (ru) | 1999-06-24 |
ES2175073T3 (es) | 2002-11-16 |
CZ230297A3 (en) | 1997-11-12 |
BR9607189A (pt) | 1997-11-11 |
BG63528B1 (bg) | 2002-04-30 |
BG101822A (bg) | 1998-04-30 |
NO319993B1 (no) | 2005-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961018B (en) | Oral dosage-forms containing a beta-lactam antibiotic. | |
ZA957670B (en) | Pharmaceutical preparation containing metformin and processes for the production thereof | |
TW263499B (bg) | ||
ZA973647B (en) | Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them. | |
ZA965237B (en) | A composition and a process for the preparation thereof | |
JO1969B1 (en) | Granulation process for the preparation of rapidly dissolving and dissolving compounds containing a high amount of the drug | |
HUT72970A (en) | Risperidone pamoate, pharmaceutical composition containing it and process for their production | |
GB9821387D0 (en) | Hydrocolloid confectionery | |
IL115920A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION | |
UA42745C2 (uk) | Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин | |
GB9517883D0 (en) | Improved pharmaceutical ion exchange resin composition | |
MXPA00012199A (es) | Composicion de goma de gelano modificada, proceso para la preparacion de la misma y uso de esta. | |
HU9700903D0 (en) | Sulfonamide-substituted chromanes, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them | |
HUT77128A (hu) | 1,2,4-Triazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
HU9601358D0 (en) | Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them | |
HU9601321D0 (en) | Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them | |
BR9909637A (pt) | Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos | |
HUP9802492A3 (en) | Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same | |
HU905725D0 (en) | Process for producing 1,4-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic preparatives containing these compounds as active substance | |
GR3036220T3 (en) | Process for reducing sulfur and vat dyes | |
PL331588A1 (en) | Granulated products containing a water-soluble compound and cellulose | |
HUP9900263A3 (en) | 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them | |
TW334424B (en) | L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them | |
HUT66204A (en) | Phytoactive compositions containing n-phosphonomethyl-clycine monoammonium salts as active ingredients and process for producing the compositions and the active ingredients |